Jennifer Zachary joined Merck as executive vice president and general counsel in April 2018. She serves as a legal advisor to the board of directors and company executives, leads the company’s office of general counsel and sets the company’s global legal strategy. She is also responsible for the company’s global compliance, safety and environment, and security functions.
Prior to joining Merck, Jennifer was a partner and associate at the international law firm Covington & Burling, LLP. She practiced in the area of pharmaceutical and medical device regulatory law and advised a wide range of manufacturers and trade associations on compliance with government requirements for the development, manufacture and sale of their products.
Earlier in her career, Jennifer served as an associate chief counsel for enforcement at the U.S. Food and Drug Administration and as a special assistant U.S. attorney in the civil division of the U.S. Attorney’s Office for the District of Columbia.
Jennifer serves on the board of directors for REGENXBIO Inc. and is a member of the audit committee. In addition, Jennifer is a board member of Code the Dream, a nonprofit organization that teaches software development to youth from diverse, low-income backgrounds.
She is a member of the bar associations for the District of Columbia, California and New Jersey. Jennifer holds a B.S. in biology and a B.A. in chemistry from Arizona State University and a J.D. from Harvard Law School.
What is Jennifer Zachary's net worth?
The estimated net worth of Jennifer Zachary is at least $8.11 million as of February 9th, 2026. Zachary owns 68,916 shares of Merck & Co., Inc. stock worth more than $8,109,346 as of February 10th. This net worth evaluation does not reflect any other assets that Zachary may own. Additionally, Zachary receives an annual salary of $2,730,000.00 as EVP at Merck & Co., Inc.. Learn More about Jennifer Zachary's net worth.
How old is Jennifer Zachary?
Zachary is currently 46 years old. There are 8 older executives and no younger executives at Merck & Co., Inc.. The oldest executive at Merck & Co., Inc. is Mr. Sanat Chattopadhyay, Executive VP & President of Merck Manufacturing Division, who is 64 years old. Learn More on Jennifer Zachary's age.
What is Jennifer Zachary's salary?
As the EVP of Merck & Co., Inc., Zachary earns $2,730,000.00 per year. There are 3 executives that earn more than Zachary. The highest earning executive at Merck & Co., Inc. is Mr. Robert M. Davis J.D., Chairman, President & CEO, who commands a salary of $5,570,000.00 per year. Learn More on Jennifer Zachary's salary.
How do I contact Jennifer Zachary?
Has Jennifer Zachary been buying or selling shares of Merck & Co., Inc.?
During the past quarter, Jennifer Zachary has sold $14,485,422.95 of Merck & Co., Inc. stock. Most recently, Jennifer Zachary sold 121,573 shares of the business's stock in a transaction on Monday, February 9th. The shares were sold at an average price of $119.15, for a transaction totalling $14,485,422.95. Following the completion of the sale, the executive vice president now directly owns 68,916 shares of the company's stock, valued at $8,211,341.40. Learn More on Jennifer Zachary's trading history.
Who are Merck & Co., Inc.'s active insiders?
Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Chirfi Guindo (CMO), Michael Holston (EVP), E III (SVP), Rita Karachun (VP), Dean Li (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), Wendell Weeks (Director), David Williams (Executive vice president, chief information & digital officer), and Jennifer Zachary (EVP). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?
During the last year, insiders at the sold shares 12 times. They sold a total of 333,052 shares worth more than $39,354,502.05. The most recent insider tranaction occured on February, 9th when CMO Chirfi Guindo sold 10,000 shares worth more than $1,184,100.00. Insiders at Merck & Co., Inc. own 0.1% of the company.
Learn More about insider trades at Merck & Co., Inc.. Information on this page was last updated on 2/9/2026.
